New Cell Cycle Inhibitors Eradicate Aneuploid Cancers

Explore groundbreaking research on novel cell cycle inhibitors and their potential to eliminate aneuploid cancers in this 57-minute grand rounds presentation from Yale Cancer Center. Learn about cutting-edge therapeutic approaches that target the unique vulnerabilities of cancer cells with abnormal chromosome numbers, examining how these new inhibitors work at the molecular level to selectively destroy aneuploid tumor cells while sparing normal diploid cells. Discover the latest clinical and preclinical data demonstrating the efficacy of these targeted treatments, understand the mechanisms underlying aneuploidy in cancer development and progression, and gain insights into how this research is translating into promising new treatment strategies for patients with various types of cancer characterized by chromosomal instability.